No annual revenue total was found in CalciMedica, Inc.'s SEC filings.
CalciMedica, Inc. (CALC) files with the SEC under industry code 2834, Pharmaceutical Preparations. Free cash flow was -$21.2 million.
Revenue
—
Net income (TTM)
$-21.24M
-1.8% vs year-ago TTM
Operating cash flow (TTM)
$-19.11M
+9.8% vs year-ago TTM
Free cash flow (TTM)
$-19.12M
+9.8% vs year-ago TTM
EPS (TTM)
$-1.33
+15.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
15.74M
+0.0% vs prior year
Net cash
$1.12M
FY 2022
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CALC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1534133
- Former names
- CalciMedica, Inc. /DE/ (until Mar 22, 2023); GRAYBUG VISION, INC. (until Mar 15, 2023); GRAYBUG, Inc. (until May 13, 2016); GRAYBUG LLC (until Oct 7, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$23.1M | -$24.2M | -$38.1M | -$14.2M | -$35.9M |
| Net income | -$29.6M | -$13.7M | -$34.4M | -$7.8M | -$35.8M |
| Diluted EPS | -$1.97 | -$1.22 | -$7.66 | -$111.16 | — |
| Operating cash flow | -$21.2M | -$21.1M | -$25.7M | -$11.8M | -$31.5M |
| Free cash flow | -$21.2M | -$21.2M | -$25.8M | -$11.8M | -$32.0M |
| Total assets | $13.6M | $19.8M | $12.2M | $3.3M | $69.1M |
| Total liabilities | $20.2M | $5.4M | $4.0M | $12.6M | $4.1M |
| Stockholders' equity | -$6.6M | $14.4M | $8.2M | -$71.3M | -$64.0M |
| Cash and investments | $13.0M | $18.7M | $11.2M | $1.3M | $63.7M |
| Total debt | — | — | — | $203,000 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 16, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Sep 16, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 2, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 27, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 20, 2026 | Aug 19, 2026 |
All 530 CalciMedica, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.